True grit: Programmed necrosis in antiviral host defense, inflammation, and immunogenicity

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2019-2026

  Mocarski, Edward S ^a   Kaiser, William J ^a   Livingston Rosanoff, Devon ^a   Upton, Jason W ^b   Daley Bauer, Lisa P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE INHIBITOR; CELL PROTEIN; DEATH RECEPTOR; INTERFERON RECEPTOR; MIXED LINEAGE KINASE; PROTEIN DAI; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 3; RECEPTOR INTERACTING PROTEIN KINASE 3; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; APOPTOSIS; CELL SPECIFICITY; CROSS PRESENTATION; CYTOLYSIS; ENZYME ACTIVATION; HOST RESISTANCE; HUMAN; IMMUNOGENICITY; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; CAPSID PROTEINS; DNA-BINDING PROTEINS; GLYCOPROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MICE; NECROSIS; NUCLEAR PORE COMPLEX PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84896541259     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302426     Document Type: Review

References (124)

1. Lamkanfi, M., and V. M. Dixit. 2010. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8: 44-54.
2. Galluzzi, L., C. Brenner, E. Morselli, Z. Touat, and G. Kroemer. 2008. Viral control of mitochondrial apoptosis. PLoS Pathog. 4: e1000018.
3. Mocarski, E. S., J. W. Upton, and W. J. Kaiser. 2012. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12: 79-88.
4. Castanier, C., and D. Arnoult. 2011. Mitochondrial localization of viral proteins as a means to subvert host defense. Biochim. Biophys. Acta 1813: 575-583.
5. Kaiser, W. J., J. W. Upton, and E. S. Mocarski. 2013. Viral modulation of programmed necrosis. Curr. Opin. Virol. 3: 296-306.
6. Green, D. R. 2010. Means to and End: Apoptosis and Other Cell Death Mechanisms. Cold Spring Harbor Press, Cold Spring Harbor, NY. 7. Moriwaki, K., and F. K. Chan. 2013. RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 27: 1640-1649.
7. Mocarski, E. S., and A. Grakoui. 2007. Persistent and Latent Infection. In Encyclopedia of Virology, 3rd Ed. B. Mahy and M. Van Regenmortel, eds. Elsevier, Oxford, U.K. p. 108-116.
8. Moquin, D., and F. K. Chan. 2010. The molecular regulation of programmed necrotic cell injury. Trends Biochem. Sci. 35: 434-441.
9. Barnaba, V., M. Paroli, and S. Piconese. 2012. The ambiguity in immunology. Front. Immunol 3: 18.
10. Kaiser, W. J., J. W. Upton, A. B. Long, D. Livingston-Rosanoff, L. P. Daley-Bauer, R. Hakem, T. Caspary, and E. S. Mocarski. 2011. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471: 368-372.
11. Green, D. R., A. Oberst, C. P. Dillon, R. Weinlich, and G. S. Salvesen. 2011. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol. Cell 44: 9-16.
12. Degterev, A., and J. Yuan. 2008. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 9: 378-390.
13. Mahr, J. A., and L. R. Gooding. 1999. Immune evasion by adenoviruses. Immunol. Rev. 168: 121-130.
14. Rahman, M. M., and G. McFadden. 2006. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2: e4.
15. McCormick, A. L., and E. S. Mocarski. 2013. Cell death pathways controlled by cytomegaloviruses. In Cytomegaloviruses: From Molecular Pathogenesis to Intervention. M. J. Reddehase, ed. Caister Scientific Press, Norfolk, U.K., p. 263-276.
16. Domm, S., J. Cinatl, and U. Mrowietz. 2008. The impact of treatment with tumour necrosis factor-Alpha antagonists on the course of chronic viral infections: a review of the literature. Br. J. Dermatol. 159: 1217-1228.
17. Bousfiha, A., C. Picard, S. Boisson-Dupuis, S. Y. Zhang, J. Bustamante, A. Puel, E. Jouanguy, F. Ailal, J. El-Baghdadi, L. Abel, and J. L. Casanova. 2010. Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 135: 204-209.
18. Micheau, O., and J. Tschopp. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190.
19. Oberst, A., C. P. Dillon, R. Weinlich, L. L. McCormick, P. Fitzgerald, C. Pop, R. Hakem, G. S. Salvesen, and D. R. Green. 2011. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471: 363-367.
20. Dillon, C. P., A. Oberst, R. Weinlich, L. J. Janke, T. B. Kang, T. Ben-Moshe, T. W. Mak, D. Wallach, and D. R. Green. 2012. Survival function of the FADDCASPASE-8-cFLIP(L) complex. Cell Rep. 1: 401-407.
21. Degterev, A., J. Hitomi, M. Germscheid, I. L. Ch'en, O. Korkina, X. Teng, D. Abbott, G. D. Cuny, C. Yuan, G. Wagner, et al. 2008. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4: 313-321.
22. Benedict, C. A., T. A. Banks, and C. F. Ware. 2003. Death and survival: viral regulation of TNF signaling pathways. Curr. Opin. Immunol. 15: 59-65.
23. Degterev, A., Z. Huang, M. Boyce, Y. Li, P. Jagtap, N. Mizushima, G. D. Cuny, T. J. Mitchison, M. A. Moskowitz, and J. Yuan. 2005. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1: 112-119.
24. Upton, J. W., W. J. Kaiser, and E. S. Mocarski. 2012. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11: 290-297.
25. Upton, J. W., W. J. Kaiser, and E. S. Mocarski. 2010. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313.
26. He, S., Y. Liang, F. Shao, and X. Wang. 2011. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108: 20054-20059.
27. Kaiser, W. J., H. Sridharan, C. Huang, P. Mandal, J. W. Upton, P. J. Gough, C. A. Sehon, R. W. Marquis, J. Bertin, and E. S. Mocarski. 2013. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288: 31268-31279.
28. Robinson, N., S. McComb, R. Mulligan, R. Dudani, L. Krishnan, and S. Sad. 2012. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13: 954-962.
29. Thapa, R. J., S. H. Basagoudanavar, S. Nogusa, K. Irrinki, K. Mallilankaraman, M. J. Slifker, A. A. Beg, M. Madesh, and S. Balachandran. 2011. NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol. Cell. Biol. 31: 2934-2946.
30. Thapa, R. J., S. Nogusa, P. Chen, J. L. Maki, A. Lerro, M. Andrake, G. F. Rall, A. Degterev, and S. Balachandran. 2013. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc. Natl. Acad. Sci. USA 110: E3109-E3118.
31. Ch'en, I. L., J. S. Tsau, J. D. Molkentin, M. Komatsu, and S. M. Hedrick. 2011. Mechanisms of necroptosis in T cells. J. Exp. Med. 208: 633-641.
32. Hedrick, S. M., I. L. Ch'en, and B. N. Alves. 2010. Intertwined pathways of programmed cell death in immunity. Immunol. Rev. 236: 41-53.
33. Tenev, T., K. Bianchi, M. Darding, M. Broemer, C. Langlais, F. Wallberg, A. Zachariou, J. Lopez, M. MacFarlane, K. Cain, and P. Meier. 2011. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43: 432-448.
34. Kersse, K., J. Verspurten, T. Vanden Berghe, and P. Vandenabeele. 2011. The death-fold superfamily of homotypic interaction motifs. Trends Biochem. Sci. 36: 541-552.
35. Vandenabeele, P., L. Galluzzi, T. Vanden Berghe, and G. Kroemer. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11: 700-714.
36. Cho, Y. S., S. Challa, D. Moquin, R. Genga, T. D. Ray, M. Guildford, and F. K. Chan. 2009. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123.
37. He, S., L. Wang, L. Miao, T. Wang, F. Du, L. Zhao, and X. Wang. 2009. Receptor interacting protein kinase-3 determines cellular necrotic response to TNFalpha. Cell 137: 1100-1111.
38. Zhang, D. W., J. Shao, J. Lin, N. Zhang, B. J. Lu, S. C. Lin, M. Q. Dong, and J. Han. 2009. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336.
39. Li, J., T. McQuade, A. B. Siemer, J. Napetschnig, K. Moriwaki, Y. S. Hsiao, E. Damko, D. Moquin, T. Walz, A. McDermott, et al. 2012. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150: 339-350.
40. Sun, L., H. Wang, Z. Wang, S. He, S. Chen, D. Liao, L. Wang, J. Yan, W. Liu, X. Lei, and X. Wang. 2012. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-227.
41. Zhao, J., S. Jitkaew, Z. Cai, S. Choksi, Q. Li, J. Luo, and Z. G. Liu. 2012. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl. Acad. Sci. USA 109: 5322-5327.
42. Cai, Z., S. Jitkaew, J. Zhao, H. C. Chiang, S. Choksi, J. Liu, Y. Ward, L. G. Wu, and Z. G. Liu. 2014. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16: 55-65.
43. Aoshi, T., S. Koyama, K. Kobiyama, S. Akira, and K. J. Ishii. 2011. Innate and adaptive immune responses to viral infection and vaccination. Curr. Opin. Virol. 1: 226-232.
44. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
45. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
46. Verma, S., and C. A. Benedict. 2011. Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus. J. Interferon Cytokine Res. 31: 211-218.
47. Kumar, H., T. Kawai, and S. Akira. 2011. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30: 16-34.
48. Wallach, D., A. Kovalenko, and T. B. Kang. 2011. 'Necrosome'-induced inflammation: must cells die for it? Trends Immunol. 32: 505-509.
49. Kaczmarek, A., P. Vandenabeele, and D. V. Krysko. 2013. Necroptosis: the release of damage-Associated molecular patterns and its physiological relevance. Immunity 38: 209-223.
50. Feoktistova, M., P. Geserick, B. Kellert, D. P. Dimitrova, C. Langlais, M. Hupe, K. Cain, M. MacFarlane, G. Häcker, and M. Leverkus. 2011. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43: 449-463.
51. Rajput, A., A. Kovalenko, K. Bogdanov, S. H. Yang, T. B. Kang, J. C. Kim, J. Du, and D. Wallach. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34: 340-351.
52. Zou, J., T. Kawai, T. Tsuchida, T. Kozaki, H. Tanaka, K. S. Shin, H. Kumar, and S. Akira. 2013. Poly IC triggers a cathepsin D-And IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 38: 717-728.
53. Chan, F. K., J. Shisler, J. G. Bixby, M. Felices, L. Zheng, M. Appel, J. Orenstein, B. Moss, and M. J. Lenardo. 2003. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278: 51613-51621.
54. Berger, A. K., and P. Danthi. 2013. Reovirus activates a caspase-independent cell death pathway. MBio 4: e00178-13.
55. Murphy, J. M., P. E. Czabotar, J. M. Hildebrand, I. S. Lucet, J. G. Zhang, S. Alvarez-Diaz, R. Lewis, N. Lalaoui, D. Metcalf, A. I. Webb, et al. 2013. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39: 443-453.
56. Xie, T., W. Peng, C. Yan, J. Wu, X. Gong, and Y. Shi. 2013. Structural insights into RIP3-mediated necroptotic signaling. Cell Rep. 5: 70-78.
57. Kotredes, K. P., and A. M. Gamero. 2013. Interferons as inducers of apoptosis in malignant cells. J. Interferon Cytokine Res. 33: 162-170.
58. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72: 3666-3670.
59. Kull, F. C., Jr., and P. Cuatrecasas. 1981. Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. J. Immunol. 126: 1279-1283.
60. Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
61. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G. H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-And TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 1172-1176.
62. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J. L. Bodmer, M. Schröter, et al. 1997. Viral FLICEinhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
63. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-Alpha-induced apoptosis by NF-kappaB. Science 274: 787-789.
64. Holler, N., R. Zaru, O. Micheau, M. Thome, A. Attinger, S. Valitutti, J. L. Bodmer, P. Schneider, B. Seed, and J. Tschopp. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1: 489-495.
65. Philippi, N., D. Walter, R. Schlatter, K. Ferreira, M. Ederer, O. Sawodny, J. Timmer, C. Borner, and T. Dandekar. 2009. Modeling system states in liver cells: survival, apoptosis and their modifications in response to viral infection. BMC Syst. Biol. 3: 97.
66. Lembo, D., M. Donalisio, A. Hofer, M. Cornaglia, W. Brune, U. Koszinowski, L. Thelander, and S. Landolfo. 2004. The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J. Virol. 78: 4278-4288.
67. Upton, J. W., W. J. Kaiser, and E. S. Mocarski. 2008. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J. Biol. Chem. 283: 16966-16970.
68. Brune, W., C. Ménard, J. Heesemann, and U. H. Koszinowski. 2001. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291: 303-305.
69. Mack, C., A. Sickmann, D. Lembo, and W. Brune. 2008. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc. Natl. Acad. Sci. USA 105: 3094-3099.
70. McCormick, A. L., A. Skaletskaya, P. A. Barry, E. S. Mocarski, and V. S. Goldmacher. 2003. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316: 221-233.
71. Cicin-Sain, L., Z. Ruzsics, J. Podlech, I. Bubić, C. Menard, S. Jonjić, M. J. Reddehase, and U. H. Koszinowski. 2008. Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J. Virol. 82: 2056-2064.
72. Lembo, D., and W. Brune. 2009. Tinkering with a viral ribonucleotide reductase. Trends Biochem. Sci. 34: 25-32.
73. Hahn, G., H. Khan, F. Baldanti, U. H. Koszinowski, M. G. Revello, and G. Gerna. 2002. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BACcloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol. 76: 9551-9555.
74. Patrone, M., E. Percivalle, M. Secchi, L. Fiorina, G. Pedrali-Noy, M. Zoppé, F. Baldanti, G. Hahn, U. H. Koszinowski, G. Milanesi, and A. Gallina. 2003. The human cytomegalovirus UL45 gene product is a late, virion-Associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol. 84: 3359-3370.
75. Müller-Sienerth, N., L. Dietz, P. Holtz, M. Kapp, G. U. Grigoleit, C. Schmuck, H. Wajant, and D. Siegmund. 2011. SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells. PLoS ONE 6: e21556.
76. Kaiser, W. J., J. W. Upton, and E. S. Mocarski. 2008. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J. Immunol. 181: 6427-6434.
77. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505.
78. Rebsamen, M., L. X. Heinz, E. Meylan, M. C. Michallet, K. Schroder, K. Hofmann, J. Vazquez, C. A. Benedict, and J. Tschopp. 2009. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep. 10: 916-922.
79. DeFilippis, V. R., D. Alvarado, T. Sali, S. Rothenburg, and K. Früh. 2010. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J. Virol. 84: 585-598.
80. Zhang, H., X. Zhou, T. McQuade, J. Li, F. K. Chan, and J. Zhang. 2011. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471: 373-376.
81. Snow, A. L., P. Pandiyan, L. Zheng, S. M. Krummey, and M. J. Lenardo. 2010. The power and the promise of restimulation-induced cell death in human immune diseases. Immunol. Rev. 236: 68-82.
82. Ch'en, I. L., D. R. Beisner, A. Degterev, C. Lynch, J. Yuan, A. Hoffmann, and S. M. Hedrick. 2008. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc. Natl. Acad. Sci. USA 105: 17463-17468.
83. Lu, J. V., B. M. Weist, B. J. Van Raam, B. S. Marro, P. Srinivas, B. D. Bell, K. A. Luhrs, T. E. Lane, G. S. Salvesen, and C. M. Walsh. 2011. Complementary roles of Fas-Associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc. Natl. Acad. Sci. USA 108: 15312-15317.
84. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
85. Ben Moshe, T., H. Barash, T. B. Kang, J. C. Kim, A. Kovalenko, E. Gross, M. Schuchmann, R. Abramovitch, E. Galun, and D. Wallach. 2007. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 45: 1014-1024.
86. Maelfait, J., and R. Beyaert. 2008. Non-Apoptotic functions of caspase-8. Biochem. Pharmacol. 76: 1365-1373.
87. Maelfait, J., E. Vercammen, S. Janssens, P. Schotte, M. Haegman, S. Magez, and R. Beyaert. 2008. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J. Exp. Med. 205: 1967-1973.
88. Kovalenko, A., J. C. Kim, T. B. Kang, A. Rajput, K. Bogdanov, O. Dittrich-Breiholz, M. Kracht, O. Brenner, and D. Wallach. 2009. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206: 2161-2177.
89. Lee, P., D. J. Lee, C. Chan, S. W. Chen, I. Ch'en, and C. Jamora. 2009. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458: 519-523.
90. Zhao, X., L. Rong, X. Zhao, X. Li, X. Liu, J. Deng, H. Wu, X. Xu, U. Erben, P. Wu, et al. 2012. TNF signaling drives myeloid-derived suppressor cell accumulation. J. Clin. Invest. 122: 4094-4104.
91. Tourneur, L., and G. Chiocchia. 2010. FADD: a regulator of life and death. Trends Immunol. 31: 260-269.
92. Northington, F. J., R. Chavez-Valdez, E. M. Graham, S. Razdan, E. B. Gauda, and L. J. Martin. 2011. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J. Cereb. Blood Flow Metab. 31: 178-189.
93. Welz, P. S., A. Wullaert, K. Vlantis, V. Kondylis, V. Fernández-Majada, M. Ermolaeva, P. Kirsch, A. Sterner-Kock, G. Van Loo, and M. Pasparakis. 2011. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477: 330-334.
94. Kang, T. B., S. H. Yang, B. Toth, A. Kovalenko, and D. Wallach. 2013. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38: 27-40.
95. Scharner, D., L. Rössig, G. Carmona, E. Chavakis, C. Urbich, A. Fischer, T. B. Kang, D. Wallach, Y. J. Chiang, Y. L. Deribe, et al. 2009. Caspase-8 is involved in neovascularization-promoting progenitor cell functions. Arterioscler. Thromb. Vasc. Biol. 29: 571-578.
96. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F. F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324: 392-397.
97. Kang, T. B., G. S. Oh, E. Scandella, B. Bolinger, B. Ludewig, A. Kovalenko, and D. Wallach. 2008. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosometransgenic mice. J. Immunol. 181: 2522-2532.
98. Ben Moshe, T., T. B. Kang, A. Kovalenko, H. Barash, R. Abramovitch, E. Galun, and D. Wallach. 2008. Cell-Autonomous and non-cell-Autonomous functions of caspase-8. Cytokine Growth Factor Rev. 19: 209-217.
99. Kang, T. B., T. Ben-Moshe, E. E. Varfolomeev, Y. Pewzner-Jung, N. Yogev, A. Jurewicz, A. Waisman, O. Brenner, R. Haffner, E. Gustafsson, et al. 2004. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173: 2976-2984.
100. Moulin, M., H. Anderton, A. K. Voss, T. Thomas, W. W. Wong, A. Bankovacki, R. Feltham, D. Chau, W. D. Cook, J. Silke, and D. L. Vaux. 2012. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J. 31: 1679-1691.
101. Vince, J. E., W. W. Wong, I. Gentle, K. E. Lawlor, R. Allam, L. O'Reilly, K. Mason, O. Gross, S. Ma, G. Guarda, et al. 2012. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36: 215-227.
102. Silke, J., and E. L. Hartland. 2013. Masters, marionettes and modulators: intersection of pathogen virulence factors and mammalian death receptor signaling. Curr. Opin. Immunol. 25: 436-440.
103. Andrews, D. M., M. J. Estcourt, C. E. Andoniou, M. E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G. R. Hill, R. G. Van der Most, et al. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207: 1333-1343.
104. Sumaria, N., S. L. Van Dommelen, C. E. Andoniou, M. J. Smyth, A. A. Scalzo, and M. A. Degli-Esposti. 2009. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol. Cell Biol. 87: 559-566.
105. Lin, M. L., Y. Zhan, J. A. Villadangos, and A.M. Lew. 2008. The cell biology of crosspresentation and the role of dendritic cell subsets. Immunol. Cell Biol. 86: 353-362.
106. Albert, M. L. 2004. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4: 223-231.
107. Ferguson, T. A., J. Choi, and D. R. Green. 2011. Armed response: how dying cells influence T-cell functions. Immunol. Rev. 241: 77-88.
108. Snyder, C. M., J. E. Allan, E. L. Bonnett, C. M. Doom, and A. B. Hill. 2010. Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS ONE 5: e9681.
109. Seckert, C. K., S. I. Schader, S. Ebert, D. Thomas, K. Freitag, A. Renzaho, J. Podlech, M. J. Reddehase, and R. Holtappels. 2011. Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J. Gen. Virol. 92: 1994-2005.
110. Hutchinson, S., S. Sims, G. O'Hara, J. Silk, U. Gileadi, V. Cerundolo, and P. Klenerman. 2011. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 6: e14646.
111. Doom, C. M., and A. B. Hill. 2008. MHC class I immune evasion in MCMV infection. Med. Microbiol. Immunol. (Berl.) 197: 191-204.
112. Snyder, C. M., K. S. Cho, E. L. Bonnett, J. E. Allan, and A. B. Hill. 2011. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog. 7: e1002295.
113. Walton, S. M., N. Torti, S. Mandaric, and A. Oxenius. 2011. T-cell help permits memory CD8(+) T-cell inflation during cytomegalovirus latency. Eur. J. Immunol. 41: 2248-2259.
114. Pulendran, B., and R. Ahmed. 2011. Immunological mechanisms of vaccination. Nat. Immunol. 12: 509-517.
115. Torti, N., S. M. Walton, K. M. Murphy, and A. Oxenius. 2011. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur. J. Immunol. 41: 2612-2618.
116. Dudek, T., and D. M. Knipe. 2006. Replication-defective viruses as vaccines and vaccine vectors. Virology 344: 230-239.
117. Paris, R. M., J. H. Kim, M. L. Robb, and N. L. Michael. 2010. Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. Expert Rev. Vaccines 9: 1055-1069.
118. Rollier, C. S., A. Reyes-Sandoval, M. G. Cottingham, K. Ewer, and A. V. Hill. 2011. Viral vectors as vaccine platforms: deployment in sight. Curr. Opin. Immunol. 23: 377-382.
119. Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527.
120. Arens, R. 2012. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors. Adv. Immunol. 114: 217-243.
121. Ebermann, L., Z. Ruzsics, C. A. Guzmán, N. Van Rooijen, R. Casalegno-Garduno, U. Koszinowski, and L.-Ci-cin-?Sain. 2012. Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. PLoS Pathog. 8: e1003062.
122. Hsu, K. M., J. R. Pratt, W. J. Akers, S. I. Achilefu, and W. M. Yokoyama. 2009. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J. Gen. Virol. 90: 33-43.
123. Daley-Bauer, L. P., and E. S. Mocarski. 2013. Myeloid cell recruitment and function in cytomegalovirus immunity and pathogenesis. In Cytomegaloviruses: From Molecular Pathogenesis to Intervention. M. J. Reddehase, ed. Caister Scientific Press, Norfolk, United Kingdom, p. 363-373.
124. Hansen, S. G., J. B. Sacha, C. M. Hughes, J. C. Ford, B. J. Burwitz, I. Scholz, R. M. Gilbride, M. S. Lewis, A. N. Gilliam, A. B. Ventura, et al. 2013. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340: 1237874.